Real-time funding, M&A, exec moves & hiring — the signals that move deals
More real-time opportunities that match your ICP — every funding, M&A, and exec move the moment it breaks, with the verified contacts to reach out first.
Funding, M&A, exec moves & hiring — every signal Fundz sees, the moment it happens. See who’s in your market, who to reach, and why now.
Senti Biosciences Holdings, Inc.
AI Executive Summary
AI-powered analysis of 8-K filing content
Senti Biosciences raised $10 million through senior secured convertible notes from Celadon Partners SPV 24 on May 20, 2026, providing capital to support ongoing gene therapy development and strengthen the company's liquidity position.
Key Takeaways
Company issued $10 million in senior secured convertible notes, indicating continued investor confidence despite biotech sector volatility
Financing was part of a previously announced Securities Purchase Agreement dated April 27, 2026, suggesting planned capital raise strategy
2 more takeaways